Dr. J. Jacques Carter

Dr. J. Jacques Carter

Primary Care Physician

Primary Care Physician

Harvard Medical School

Dr. J. Jacques Carter currently serves as an attending physician at the Beth Israel Deaconess Medical Center in Boston and is an assistant professor of medicine at Harvard Medical School. From 2005 to 2014, he also served as the Medical Director of the Prostate Cancer Screening and Education Program at the Dana-Farber Cancer Institute in Boston. Dr. Carter serves as a medical advisor for PHEN and a member of its board of directors. 

Dr. Carter has been active in a number of civic and community organizations, including past board president of the Family Service of Greater Boston and past chair of the Brookline Advisory Council on Public Health. 

He has earned degrees from Howard University and George Washington University and received his medical degree from Georgetown University in Washington, D.C. Dr. Carter completed his residency training in Internal Medicine at Beth Israel Deaconess Medical Center in Boston. Then, Dr. Carter completed a graduate program at the Harvard School of Public Health where he received his Master of Public Health (MPH) degree. 

He then completed a clinical fellowship in primary care medicine at Massachusetts General Hospital. Since completing his training, Dr. Carter has held a number of clinical and administrative positions, including medical directorships of several local and national healthcare organizations. 

As a former director of one of the major clinical clerkships, he now serves as a teacher, advisor, and mentor for students at Harvard College, Harvard Medical School, and the School of Public Health. He regularly gives talks on medical and health-related topics to community groups and students throughout the Greater Boston area. He also lectures nationally and internationally on medical and public health topics. Dr. Carter serves as a medical consultant and resource for members of the print and electronic media.  

Mr. Jerry Womack

Mr. Jerry Womack

Prostate Cancer Survivor and PHEN Ambassador

Prostate Cancer Survivor and PHEN Ambassador

Mr. Jerry Womack is a U.S. Air Force Veteran and a retired Sales & Building Environmental Services Executive. He is a long-term PHEN advocate and one of the original PHEN Survivor Network Members. He served as the leader of the “Man to Man” support group component of PHEN’s monthly Managing Survivorship Meetings. After relocating to Charlotte, North Carolina in 2015, Mr. Womack became PHEN Ambassador for the Charlotte, NC area. 

He is a prostate cancer survivor and ambassador for the Prostate Health Education Network. As a prostate cancer survivor, he was diagnosed in the early stages due to early detection methods. He underwent multiple treatment options and was able to receive treatment while the cancer was in a low-grade status and believed to be contained. With a blessing from God for extended life, he has been on a mission to share with everyone who will listen about the importance of managing prostate health through early detection and frequent follow-up visits.

Dr. Peter Francis

Dr. Peter Francis

Global Medical Affairs Lead, Early Prostate Cancer

Global Medical Affairs Lead, Early Prostate Cancer

Johnson & Johnson

Dr. Peter Francis joined Janssen Oncology in the US in October 2015 as a Medical Director focusing on prostate cancer, specifically abiraterone acetate with prednisone, apalutamide and niraparib. He participated in multiple work streams in support of the prostate cancer franchise including key opinion leader engagement, advisory boards, promotional material review, business development, Real World evidence gathering as well as Sales Specialist and MSL training. He has also helped to develop several new clinical study concepts to fill in knowledge gaps in the management of prostate cancer.

He obtained his medical degree at the New York University School of Medicine in 1985 and finished a three-year internship and residency in Internal Medicine at the Boston Medical Center (combination of Boston University and Boston City Hospitals). He then spent 4 and ½ years at the National Cancer Institute, specializing in the preclinical development of antifungal drugs in a novel animal model system that is still generating data today.

Peter draws on over 22 years of experience as a practicing hematologist-oncologist in Northern Virginia where he cared for patients with an extensive array of solid tumors and malignant and benign hematologic disorders, placing dozens of patients on clinical trials sponsored by the NCI as well as industry partners.

In 2007, Peter was in the graduating class of the George Washington University School of Business, completing a 2-year MBA program in Health Care with special interests in Health Policy and Pharmacoeconomics.

He has been on the Global Medical Affairs team as the GMAL for niraparib and early prostate cancer assets. He looks forward to daily challenges in advancing niraparib in the management of prostate cancer and introducing novel pipeline agents in solid tumors to internal and external stakeholders.

Mr. William Joseph Davis, Jr.

Mr. William Joseph Davis, Jr.

Prostate Cancer Survivor Caregiver

Prostate Cancer Survivor Caregiver

William Joseph Davis Jr., is a native South Carolinian, 21 years Army veteran with multiple deployments under his belt including Desert Storm.  Prostate cancer has had a significant impact on the life of the men in his family.  Mr. Davis’s father, William Sr. was diagnosed with prostate cancer in 2014 and eventually succumbed to the disease in 2019.   One of Mr. Davis’s brothers was diagnosed with prostate cancer in 2020. Mr. Davis serves as a Veteran’s Service Officer for the American Legion where he proudly represents veterans to the VA.  He and his wife Linda reside in Denver, Colorado.  They are the proud parents of 5 children and 2 grandchildren.   Mr. Davis is a vocal advocate for awareness, education, and action on all health issues within the African American and Veteran communities.

Mr. Norman Ceasar

Mr. Norman Ceasar

Prostate Cancer Survivor

Prostate Cancer Survivor

Port Lucie, FL

Mr. Norman Ceasar was born and raised in Washington, DC. I attended the District of Columbia Public Schools and graduated from Woodward Preparatory School and later took classes at the University of the District of Columbia, UDC. Worked for the US Postal Service until I retired, after 34 years of service, in 2009. Part-time during those years, I also invested in Real Estate. I purchased houses that needed work, renovated them, and then rented them out.

I was inspired to write this book on surviving prostate cancer because of my experience with the disease, I realized the importance of making other men aware and educating them about prostate cancer. Too many men have died and are dying from prostate cancer. For those who died, their deaths may have been avoided with just a little more knowledge about the disease. It is highly curable if caught early.

My mission is to tell my story of how I survived prostate cancer. Mainly because cancer was detected early when it is most curable. I survived prostate cancer by getting my physical and my blood work done every year in January my birth month starting at age 35.

I wanted to live and be here for my family. I believed God had more for me to do. I prayed for His wisdom and then took the steps necessary to make that happen. I did the research necessary to become informed of my options, talking with my doctors, and family, and finally choosing the best treatment for myself. I had to fight the battle in my mind when thoughts of doubt of my decisions would rear its head.

Dr. Christina M. Dieli-Conwright

Dr. Christina M. Dieli-Conwright

Associate Professor of Medicine

Associate Professor of Medicine

Harvard Medical School, Dana-Farber Cancer Institute

Christina M. Dieli-Conwright, PhD, MPH received her BS in Biological Sciences from California Polytechnic State University San Luis Obispo and her MS in Kinesiology from California State University Northridge. She earned a MPH, and PhD in Biokinesiology from the University of Southern California. Following a postdoctoral fellowship in Cancer Etiology at the City of Hope National Medical Center, she was the Director of the Integrative Center for Oncology Research in Exercise and Assistant Professor of Biokinesiology and Medicine at the University of Southern California. In 2020, she joined the faculty of the Dana-Farber Cancer Institute and Harvard Medical School.